Loading...
Elevance Health Inc.
ANTM•NYSE
HealthcareMedical - Healthcare Plans
$482.58
$12.71(2.71%)
Elevance Health Inc. (ANTM) Financial Performance & Statements
Review Elevance Health Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
3.19%
↑ 3.19%
Operating Income Growth
1469.31%
↑ 1469.31%
Net Income Growth
-0.12%
↓ 0.12%
Operating Cash Flow Growth
-27.95%
↓ 27.95%
Operating Margin
4.30%
↑ 4.30%
Gross Margin
62.59%
↑ 62.59%
Net Profit Margin
3.23%
↑ 3.23%
ROE
13.94%
↑ 13.94%
ROIC
10.23%
↑ 10.23%
Elevance Health Inc. (ANTM) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Elevance Health Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $45.44B | $45.15B | $43.65B | $42.58B |
| Cost of Revenue | $0.00 | $32.95B | $30.57B | $30.55B |
| Gross Profit | $45.44B | $12.20B | $13.07B | $12.03B |
| Gross Profit Ratio | $1.00 | $0.27 | $0.00 | $0.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $45.44B | $10.48B | $10.05B | $8.83B |
| Total Costs & Expenses | $45.44B | $43.43B | $40.62B | $39.37B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $340.00M | $300.00M | $280.00M | $265.00M |
| Depreciation & Amortization | -$995.00M | $329.00M | $335.00M | $331.00M |
| EBITDA | -$49.00M | $2.002B | $3.60B | $3.54B |
| EBITDA Ratio | -$0.001 | $0.04 | -$0.001 | $0.80 |
| Operating Income | $0.00 | $1.71B | $3.03B | $3.20B |
| Operating Income Ratio | $0.00 | $0.04 | $0.07 | $0.08 |
| Other Income/Expenses (Net) | $606.00M | -$339.00M | -$40.00M | -$265.00M |
| Income Before Tax | $606.00M | $1.37B | $2.99B | $2.94B |
| Income Before Tax Ratio | $0.01 | $0.03 | $0.07 | $0.07 |
| Income Tax Expense | $193.00M | $365.00M | $685.00M | $690.00M |
| Net Income | $418.00M | $1.02B | $2.30B | $2.25B |
| Net Income Ratio | $0.009 | $0.02 | $0.05 | $0.05 |
| EPS | $1.81 | $4.36 | $9.91 | $9.65 |
| Diluted EPS | $1.81 | $4.36 | $9.85 | $9.59 |
| Weighted Avg Shares Outstanding | $231.10M | $233.03M | $232.20M | $232.70M |
| Weighted Avg Shares Outstanding (Diluted) | $231.10M | $233.10M | $233.40M | $234.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan